Edgewell Personal Care vs Interparfums
EPC and IPAR side by side, both in soap, detergents, and cleaning preparations; perfumes, cosmetics, and other toilet preparations. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EPC and IPAR compare
Interparfums is the larger company, worth 2.8 times as much as Edgewell Personal Care ($3.7B against $1.3B).
Edgewell Personal Care grew revenue faster over the last twelve months (11.6% versus 2.9% for Interparfums).
Interparfums keeps more of each dollar of sales as profit, with a net margin of 11.2% compared with −4.2% at Edgewell Personal Care.
Both pay dividends: Edgewell Personal Care yields 2.1% and Interparfums 2.7%.
Interparfums scores higher on the StockData Score (19 against 7 for Edgewell Personal Care), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EPC | IPAR |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | $3.7B |
| Share price | $28.57 | $116.37 |
| Change, 1 year | 50.7% | 26.9% |
| Change, 5 years | −25.6% | 22.5% |
| Beta (5Y) | 0.67 | 0.90 |
| Employees | 6,700 | 662 |
| StockData Score | ||
| Total score | 7 | 19 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 2 | 2 |
| Performance score | 0 | 6 (better) |
| Health score | 2 | 5 (better) |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | – | 22.3× |
| P/S | 0.6× (better) | 2.5× |
| P/B | 0.9× (better) | 4.3× |
| EV/EBITDA | 21.6× | 14.3× (better) |
| P/FCF | 25.1× | 15.2× (better) |
| PEG | – | 1.93 |
| FCF yield | 4.0% | 6.6% (better) |
| Fair value | – | $119.90 |
| Margin of safety | – | 2.9% |
| Growth | ||
| Revenue growth (TTM) | 11.6% (better) | 2.9% |
| Revenue growth, 5Y average | 2.7% | 22.5% (better) |
| Net income growth (TTM) | −244% | 4.2% (better) |
| EPS growth (TTM) | −247% | 4.6% (better) |
| EPS growth, 5Y average | −15.6% | 34.1% (better) |
| Profitability | ||
| Gross margin | 39.5% | 63.8% (better) |
| Operating margin | 0.80% | 17.3% (better) |
| Net margin | −4.2% | 11.2% (better) |
| FCF margin | 2.3% | 16.4% (better) |
| Return on equity | −6.2% | 19.6% (better) |
| Return on invested capital | 0.56% | 20.2% (better) |
| Financial health | ||
| Debt / equity | 0.85 | 0.16 (better) |
| Net debt / EBITDA | 8.47 | 0.36 (better) |
| Interest coverage | 0.3× | 38.1× (better) |
| Current ratio | 1.84 | 3.31 (better) |
| Altman Z-score | 1.60 | 8.50 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 2.1% | 2.7% (better) |
| Payout ratio | – | 61.2% |
| Years of dividend growth | – | 5 |
| Dividend growth, 5Y average | – | 57.5% |
| Buyback yield | 1.2% (better) | 0.42% |
| Shareholder yield | 3.3% (better) | 3.2% |
| Ownership | ||
| Held by institutions | 117% | 67.1% |
| Held by insiders | 1.5% | 22.3% |
| Insider net buying, 12 months | −$5.7K (better) | −$4.0M |
| Short interest, % of float | 10.4% | 8.2% |
Go deeper
- EPC stock overview
- EPC income statement
- EPC valuation and score
- IPAR stock overview
- IPAR income statement
- IPAR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.